BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for...

|About: BioMarin Pharmaceutical Inc. (BMRN)|By:, SA News Editor

BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for the expansion of its manufacturing facility in Novato, CA. The facility will support will the company's enzyme replacement therapy portfolio, and provide up to $1B in revenue.